{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,2,11]],"date-time":"2026-02-11T17:12:54Z","timestamp":1770829974581,"version":"3.50.1"},"reference-count":35,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2025,12,3]],"date-time":"2025-12-03T00:00:00Z","timestamp":1764720000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2025,12,3]],"date-time":"2025-12-03T00:00:00Z","timestamp":1764720000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["AAPS J"],"DOI":"10.1208\/s12248-025-01174-y","type":"journal-article","created":{"date-parts":[[2025,12,3]],"date-time":"2025-12-03T17:51:45Z","timestamp":1764784305000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["The Impact of Cognate Antigen Binding on the FcRn-mediated Transcytosis and Recycling of Monoclonal Antibodies"],"prefix":"10.1208","volume":"28","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-4365-4157","authenticated-orcid":false,"given":"Sharon","family":"Vijayanand","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-5989-641X","authenticated-orcid":false,"given":"H. A. Daniel","family":"Lagasse","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-2904-6574","authenticated-orcid":false,"given":"Million A.","family":"Tegenge","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-8202-5188","authenticated-orcid":false,"given":"Zuben E.","family":"Sauna","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-0449-2906","authenticated-orcid":false,"given":"Basil","family":"Golding","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2025,12,3]]},"reference":[{"key":"1174_CR1","doi-asserted-by":"publisher","first-page":"1304365","DOI":"10.3389\/fimmu.2023.1304365","volume":"14","author":"T Damelang","year":"2024","unstructured":"Damelang T, Brinkhaus M, van Osch TL, Schuurman J, Labrijn AF, Rispens T, et al. Impact of structural modifications of IgG antibodies on effector functions. Front Immunol. 2024;14:1304365.","journal-title":"Front Immunol"},{"issue":"7","key":"1174_CR2","doi-asserted-by":"publisher","first-page":"1881","DOI":"10.1111\/ajt.15366","volume":"19","author":"WM Baldwin III","year":"2019","unstructured":"Baldwin WM III, Valujskikh A, Fairchild RL. The neonatal Fc receptor: key to homeostasic control of IgG and IgG-related biopharmaceuticals. Am J Transplant. 2019;19(7):1881\u20137.","journal-title":"Am J Transplant"},{"issue":"7","key":"1174_CR3","doi-asserted-by":"publisher","first-page":"415","DOI":"10.1038\/s41577-022-00821-1","volume":"23","author":"M Pyzik","year":"2023","unstructured":"Pyzik M, Kozicky LK, Gandhi AK, Blumberg RS. The therapeutic age of the neonatal Fc receptor. Nat Rev Immunol. 2023;23(7):415\u201332.","journal-title":"Nat Rev Immunol"},{"key":"1174_CR4","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2019.01540","volume":"10","author":"M Pyzik","year":"2019","unstructured":"Pyzik M, Sand KM, Hubbard JJ, Andersen JT, Sandlie I, Blumberg RS. The neonatal Fc receptor (FcRn): a misnomer? Front Immunol. 2019;10:1540.","journal-title":"Front Immunol"},{"issue":"1","key":"1174_CR5","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1007\/s40268-020-00330-3","volume":"21","author":"MA Tegenge","year":"2021","unstructured":"Tegenge MA, Mahmood I, Struble E, Golding B. Dosing considerations for antibodies against COVID-19. Drugs R D. 2021;21(1):1\u20138.","journal-title":"Drugs R D"},{"issue":"11","key":"1174_CR6","doi-asserted-by":"publisher","first-page":"e883","DOI":"10.1016\/S2666-5247(23)00194-5","volume":"4","author":"E Stadler","year":"2023","unstructured":"Stadler E, Chai KL, Schlub TE, Cromer D, Khan SR, Polizzotto MN, et al. Determinants of passive antibody efficacy in SARS-CoV-2 infection: a systematic review and meta-analysis. The Lancet Microbe. 2023;4(11):e883\u201392.","journal-title":"The Lancet Microbe"},{"issue":"1","key":"1174_CR7","doi-asserted-by":"publisher","first-page":"21","DOI":"10.1007\/s15010-022-01825-8","volume":"51","author":"J Deng","year":"2023","unstructured":"Deng J, Heybati K, Ramaraju HB, Zhou F, Rayner D, Heybati S. Differential efficacy and safety of anti-SARS-CoV-2 antibody therapies for the management of COVID-19: a systematic review and network meta-analysis. Infection. 2023;51(1):21\u201335.","journal-title":"Infection"},{"issue":"1","key":"1174_CR8","doi-asserted-by":"publisher","first-page":"e459","DOI":"10.1093\/cid\/ciab854","volume":"75","author":"CB Stauft","year":"2022","unstructured":"Stauft CB, Tegenge M, Khurana S, Lee Y, Selvaraj P, Golding H, et al. Pharmacokinetics and efficacy of human hyperimmune intravenous immunoglobulin treatment of severe acute respiratory syndrome coronavirus 2 infection in adult Syrian hamsters. Clin Infect Dis. 2022;75(1):e459\u201365.","journal-title":"Clin Infect Dis"},{"issue":"5","key":"1174_CR9","doi-asserted-by":"publisher","DOI":"10.1242\/jcs.235416","volume":"133","author":"WH Toh","year":"2020","unstructured":"Toh WH, Louber J, Mahmoud IS, Chia J, Bass GT, Dower SK, et al. FCRn mediates fast recycling of endocytosed albumin and IgG from early macropinosomes in primary macrophages. J Cell Sci. 2020;133(5):jcs235416.","journal-title":"J Cell Sci"},{"issue":"45","key":"1174_CR10","doi-asserted-by":"publisher","first-page":"14649","DOI":"10.1021\/bi00045a005","volume":"34","author":"M Raghavan","year":"1995","unstructured":"Raghavan M, Bonagura VR, Morrison SL, Bjorkman PJ. Analysis of the pH dependence of the neonatal Fc receptor\/immunoglobulin G interaction using antibody and receptor variants. Biochemistry. 1995;34(45):14649\u201357.","journal-title":"Biochemistry"},{"issue":"12","key":"1174_CR11","doi-asserted-by":"publisher","first-page":"5490","DOI":"10.1091\/mbc.e07-02-0101","volume":"19","author":"NA Goebl","year":"2008","unstructured":"Goebl NA, Babbey CM, Datta-Mannan A, Witcher DR, Wroblewski VJ, Dunn KW. Neonatal Fc receptor mediates internalization of Fc in transfected human endothelial cells. Mol Biol Cell. 2008;19(12):5490\u2013505.","journal-title":"Mol Biol Cell"},{"issue":"6","key":"1174_CR12","doi-asserted-by":"publisher","first-page":"777","DOI":"10.1007\/s10875-010-9468-4","volume":"30","author":"TT Kuo","year":"2010","unstructured":"Kuo TT, Baker K, Yoshida M, Qiao S-W, Aveson VG, Lencer WI, et al. Neonatal Fc receptor: from immunity to therapeutics. J Clin Immunol. 2010;30(6):777\u201389.","journal-title":"J Clin Immunol"},{"issue":"7","key":"1174_CR13","doi-asserted-by":"publisher","first-page":"903","DOI":"10.1172\/JCI6968","volume":"104","author":"BL Dickinson","year":"1999","unstructured":"Dickinson BL, Badizadegan K, Wu Z, Ahouse JC, Zhu X, Simister NE, et al. Bidirectional FcRn-dependent IgG transport in a polarized human intestinal epithelial cell line. J Clin Invest. 1999;104(7):903\u201311.","journal-title":"J Clin Invest"},{"issue":"15","key":"1174_CR14","doi-asserted-by":"publisher","first-page":"2398","DOI":"10.1091\/mbc.e13-04-0174","volume":"24","author":"AW Weflen","year":"2013","unstructured":"Weflen AW, Baier N, Tang Q-J, Van den Hof M, Blumberg RS, Lencer WI, et al. Multivalent immune complexes divert FcRn to lysosomes by exclusion from recycling sorting tubules. Mol Biol Cell. 2013;24(15):2398\u2013405.","journal-title":"Mol Biol Cell"},{"issue":"1","key":"1174_CR15","doi-asserted-by":"publisher","DOI":"10.1080\/19420862.2020.1802135","volume":"12","author":"Y Sun","year":"2020","unstructured":"Sun Y, Estevez A, Schlothauer T, Wecksler AT. Antigen physiochemical properties allosterically effect the IgG Fc-region and Fc neonatal receptor affinity. MAbs. 2020;12(1):1802135.","journal-title":"MAbs"},{"issue":"27","key":"1174_CR16","doi-asserted-by":"publisher","first-page":"9337","DOI":"10.1073\/pnas.0801717105","volume":"105","author":"S-W Qiao","year":"2008","unstructured":"Qiao S-W, Kobayashi K, Johansen F-E, Sollid LM, Andersen JT, Milford E, et al. Dependence of antibody-mediated presentation of antigen on FcRn. Proc Natl Acad Sci. 2008;105(27):9337\u201342.","journal-title":"Proc Natl Acad Sci"},{"key":"1174_CR17","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2014.00140","volume":"5","author":"B Platzer","year":"2014","unstructured":"Platzer B, Stout M, Fiebiger E. Antigen cross-presentation of immune complexes. Front Immunol. 2014;5:140.","journal-title":"Front Immunol"},{"issue":"2","key":"1174_CR18","doi-asserted-by":"publisher","DOI":"10.3390\/v16020217","volume":"16","author":"D Focosi","year":"2024","unstructured":"Focosi D, Casadevall A, Franchini M, Maggi F. Sotrovimab: a review of its efficacy against SARS-CoV-2 variants. Viruses. 2024;16(2):217.","journal-title":"Viruses"},{"issue":"7815","key":"1174_CR19","doi-asserted-by":"publisher","first-page":"290","DOI":"10.1038\/s41586-020-2349-y","volume":"583","author":"D Pinto","year":"2020","unstructured":"Pinto D, Park Y-J, Beltramello M, Walls AC, Tortorici MA, Bianchi S, et al. Cross-neutralization of SARS-CoV-2 by a human monoclonal SARS-CoV antibody. Nature. 2020;583(7815):290\u20135.","journal-title":"Nature"},{"issue":"6496","key":"1174_CR20","doi-asserted-by":"publisher","first-page":"1274","DOI":"10.1126\/science.abc2241","volume":"368","author":"Y Wu","year":"2020","unstructured":"Wu Y, Wang F, Shen C, Peng W, Li D, Zhao C, et al. A noncompeting pair of human neutralizing antibodies block COVID-19 virus binding to its receptor ACE2. Science. 2020;368(6496):1274\u20138.","journal-title":"Science"},{"issue":"4","key":"1174_CR21","doi-asserted-by":"publisher","first-page":"1746","DOI":"10.1091\/mbc.e03-11-0832","volume":"15","author":"SM Claypool","year":"2004","unstructured":"Claypool SM, Dickinson BL, Wagner JS, Johansen F-E, Venu N, Borawski JA, et al. Bidirectional transepithelial IgG transport by a strongly polarized basolateral membrane Fc\u03b3-receptor. Mol Biol Cell. 2004;15(4):1746\u201359.","journal-title":"Mol Biol Cell"},{"issue":"31","key":"1174_CR22","doi-asserted-by":"publisher","first-page":"28038","DOI":"10.1074\/jbc.M202367200","volume":"277","author":"SM Claypool","year":"2002","unstructured":"Claypool SM, Dickinson BL, Yoshida M, Lencer WI, Blumberg RS. Functional reconstitution of human FcRn in Madin-Darby canine kidney cells requires co-expressed human \u03b22-microglobulin. J Biol Chem. 2002;277(31):28038\u201350.","journal-title":"J Biol Chem"},{"key":"1174_CR23","doi-asserted-by":"crossref","unstructured":"Chung S, Nguyen V, Lin YL, Lafrance-Vanasse J, Scales SJ, Lin K, et al., editors. An in vitro FcRn-dependent transcytosis assay as a screening tool for predictive assessment of nonspecific clearance of antibody therapeutics in humans. MAbs. 2019;11(2):942\u201355. Taylor & Francis.","DOI":"10.1080\/19420862.2019.1605270"},{"issue":"1","key":"1174_CR24","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-018-03061-x","volume":"9","author":"A Grevys","year":"2018","unstructured":"Grevys A, Nilsen J, Sand KM, Daba MB, \u00d8ynebr\u00e5ten I, Bern M, et al. A human endothelial cell-based recycling assay for screening of FcRn targeted molecules. Nat Commun. 2018;9(1):621.","journal-title":"Nat Commun"},{"issue":"14","key":"1174_CR25","doi-asserted-by":"publisher","first-page":"1135","DOI":"10.4155\/bio-2021-0099","volume":"13","author":"C Liu","year":"2021","unstructured":"Liu C, Kim YS, Lowe JH-N, Chung S. A cell-based FcRn-dependent recycling assay for predictive pharmacokinetic assessment of therapeutic antibodies. Bioanalysis. 2021;13(14):1135\u201344.","journal-title":"Bioanalysis"},{"issue":"3","key":"1174_CR26","doi-asserted-by":"publisher","first-page":"667","DOI":"10.1007\/s00259-022-06012-3","volume":"50","author":"TA Aweda","year":"2023","unstructured":"Aweda TA, Cheng S-H, Lenhard SC, Sepp A, Skedzielewski T, Hsu C-Y, et al. In vivo biodistribution and pharmacokinetics of sotrovimab, a SARS-CoV-2 monoclonal antibody, in healthy cynomolgus monkeys. Eur J Nucl Med Mol Imaging. 2023;50(3):667\u201378.","journal-title":"Eur J Nucl Med Mol Imaging"},{"key":"1174_CR27","doi-asserted-by":"crossref","unstructured":"Haraya K, Ichikawa T, Murao N, Katada H, Kuramochi T. Prediction of human pharmacokinetics of Fc-engineered therapeutic monoclonal antibodies using human FcRn transgenic mice. InMabs. 2025;17(1):2484443. Taylor & Francis.","DOI":"10.1080\/19420862.2025.2484443"},{"issue":"7524","key":"1174_CR28","doi-asserted-by":"publisher","first-page":"642","DOI":"10.1038\/nature13612","volume":"514","author":"S-Y Ko","year":"2014","unstructured":"Ko S-Y, Pegu A, Rudicell RS, Yang Z-y, Joyce MG, Chen X, et al. Enhanced neonatal Fc receptor function improves protection against primate SHIV infection. Nature. 2014;514(7524):642\u20135.","journal-title":"Nature"},{"issue":"1","key":"1174_CR29","doi-asserted-by":"publisher","first-page":"6073","DOI":"10.1038\/s41467-022-33764-1","volume":"13","author":"M Brinkhaus","year":"2022","unstructured":"Brinkhaus M, Pannecoucke E, van der Kooi EJ, Bentlage AE, Derksen NI, Andries J, et al. The fab region of IgG impairs the internalization pathway of FcRn upon Fc engagement. Nat Commun. 2022;13(1):6073.","journal-title":"Nat Commun"},{"issue":"7212","key":"1174_CR30","doi-asserted-by":"publisher","first-page":"542","DOI":"10.1038\/nature07255","volume":"455","author":"W He","year":"2008","unstructured":"He W, Ladinsky MS, Huey-Tubman KE, Jensen GJ, McIntosh JR, Bj\u00f6rkman PJ. Fcrn-mediated antibody transport across epithelial cells revealed by electron tomography. Nature. 2008;455(7212):542\u20136.","journal-title":"Nature"},{"issue":"19","key":"1174_CR31","doi-asserted-by":"publisher","first-page":"5997","DOI":"10.1073\/pnas.1408766112","volume":"112","author":"A Schoch","year":"2015","unstructured":"Schoch A, Kettenberger H, Mundigl O, Winter G, Engert J, Heinrich J, et al. Charge-mediated influence of the antibody variable domain on FcRn-dependent pharmacokinetics. Proc Natl Acad Sci U S A. 2015;112(19):5997\u20136002.","journal-title":"Proc Natl Acad Sci U S A"},{"issue":"10","key":"1174_CR32","doi-asserted-by":"publisher","first-page":"2850","DOI":"10.4049\/jimmunol.2000732","volume":"205","author":"S Rossini","year":"2020","unstructured":"Rossini S, No\u00e9 R, Daventure V, Lecerf M, Justesen S, Dimitrov JD. V region of IgG controls the molecular properties of the binding site for neonatal Fc receptor. J Immunol. 2020;205(10):2850\u201360.","journal-title":"J Immunol"},{"key":"1174_CR33","doi-asserted-by":"crossref","unstructured":"Sun Y, Estevez A, Schlothauer T, Wecksler AT. Antigen physiochemical properties allosterically effect the IgG Fc-region and Fc neonatal receptor affinity. InMAbs. 2020;12(1):1802135. Taylor & Francis.","DOI":"10.1080\/19420862.2020.1802135"},{"issue":"8","key":"1174_CR34","doi-asserted-by":"publisher","first-page":"1545","DOI":"10.1124\/dmd.112.045864","volume":"40","author":"A Datta-Mannan","year":"2012","unstructured":"Datta-Mannan A, Chow C-K, Dickinson C, Driver D, Lu J, Witcher DR, et al. Fcrn affinity-pharmacokinetic relationship of five human IgG4 antibodies engineered for improved in vitro Fcrn binding properties in cynomolgus monkeys. Drug Metab Dispos. 2012;40(8):1545\u201355.","journal-title":"Drug Metab Dispos"},{"key":"1174_CR35","doi-asserted-by":"crossref","unstructured":"Datta-Mannan A, Lu J, Witcher DR, Leung D, Tang Y, Wroblewski VJ. The interplay of non-specific binding, target-mediated clearance and FcRn interactions on the pharmacokinetics of humanized antibodies.\u00a0InMAbs. 2015;7(6):1084\u201393. Taylor & Francis.","DOI":"10.1080\/19420862.2015.1075109"}],"container-title":["The AAPS Journal"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1208\/s12248-025-01174-y.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1208\/s12248-025-01174-y","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1208\/s12248-025-01174-y.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,2,11]],"date-time":"2026-02-11T16:20:52Z","timestamp":1770826852000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1208\/s12248-025-01174-y"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,12,3]]},"references-count":35,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2026,1]]}},"alternative-id":["1174"],"URL":"https:\/\/doi.org\/10.1208\/s12248-025-01174-y","relation":{},"ISSN":["1550-7416"],"issn-type":[{"value":"1550-7416","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,12,3]]},"assertion":[{"value":"7 August 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"19 October 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"3 December 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"B.G., Z.E.S., M.A.T., D.L., and S.V. have no financial competing interests.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}},{"value":"Our contributions are an informal communication and represent our own best judgement. These comments do not bind or obligate FDA\n                      .","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Disclaimer"}}],"article-number":"24"}}